Pneumococcal immunization after heart and lung transplantation: Immune response in immune-suppressed patients and in healthy controls;Pneumokokkenimpfung nach Herz- und Lebertransplantation. Immunantworten bei immunsupprimierten Patienten und gesunden Kontrollpersonen

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 49, 1996, Pages 1519-1525

  Dengler, T J ^a,b   Strnad, N ^a,c   Zimmermann, R ^a,b   Allers, C ^a,c   Markus, B H ^a,c   V Nessen, S ^a,c   Kubler W ^a,b   Zielen, S ^a,c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PNEUMOCOCCUS VACCINE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MALE; STREPTOCOCCUS PNEUMONIAE;

EID: 0029989422     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043177     Document Type: Article

References (37)

1. Amber, I. J., E. M. Gilbert, G. Schiffmann, J. A. Jacobson: Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 49 (1990), 122-125.
2. Appelbaum, P. C.: Antimicrobial resistance in Streptococcus pneumoniae. An overview. Clin. Inf. Dis. 15 (1992), 77-83.
3. Barkholt, L. B., B. G. Ericson, J. Tollemar, A. S. Malmborg, A. Ehrnst, H. Wilczek, J. Andersson: Infections in human liver recipients. Different patterns early and late after transplantation. Transplant, int. 6 (1993), 77-84.
4. Bolan, G., C. V. Broom, R. R. Facklam, B. D. Plikaytis, D. W. Fraser, W. B. Schlech: Pneumococcal vaccine efficacy in selected populations in the United States. Ann. intern. Med. 104 (1986), 1-6.
5. Broom, C. V., R. R. Facklam, D. Fraser: Pneumococcal disease after pneumococcal vaccination. New Engl. J. Med. 303 (1980), 549-552.
6. Bruyn, G. A. W., R. van Furth: Pneumococcal polysaccharide vaccines. Indications, efficacy and recommendations. Europ. J. Microbiol. Infect. Dis. 10 (1991), 897-910.
7. Butler, J. C., R. F. Breiman, J. F. Campbell, H. B. Lipman, C. V. Broome, R. R. Facklam: Pneumococcal polysaccharide vaccine efficacy. J. Amer. med. Ass. 270 (1993), 1826-1831.
8. Centers for Disease Control: Pneumococcal polysaccharide vaccine. Morbid. Mortal. Wkly Rep. 38 (1989), 64-68.
9. Fedson, D. S.: Pneumococcal vaccine. In Plotkin, S. A., E. A. J. Mortimer (Ed.): Vaccines (Saunders: Philadelphia 1988), 271-299.
10. Fine, M. J., M. A. Smith, C. C. Carson, F. Meffe, S. S. Sankey, L. A. Weissfeld, A. S. Detsky, W. N. Kapoor: Efficacy of pneumococcal vaccination in adults. Arch. intern. Med. 154 (1994), 2666-2667.
11. Giebink, G. S., C. T. Le, J. S. Spika: Summarized versus type-specific analysis of antibody to pneumococcal capsular polysaccharides. Rev. infect. Dis. 3 (1981), S43-S50.
12. Grekas, D., P. Alivanis, V. Kirizopoulou, C. Dioudis, A. Sioulis, V. Derveniotis, A. Tourkantonis: Influenza vaccination on renal transplant patients is safe and serologically effective. Int. clin. Pharmacol. Ther. Toxicol. 31 (1993), 553-556.
13. Griffioen, A. W., L. Sanders, G. T. Rijkers, B. J. Zegers: Cell biology of B lymphocyte activation by polysaccharides. J. infect. Dis. (1992).
14. Hirshmann, B. A.: The pneumococcal vaccine after 15 years of use. Arch. intern. Med. 154 (1994), 373-377.
15. Kraemer-Hansen, D., D. Henne-Bruns, B. Kremer: Probleme der Langzeitimmunsuppression nach Organtransplantation. Dtsch. med. Wschr. 119 (1994), 807-812.
16. Landesman, S. H., G. Schiffmann: Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev. Inf. Dis. 3 (1981), S184-S196.
17. Lane, J., I. C. M. MacLennan: Impaired IgG 2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG 2 levels but no IgA. Clin. exp. Immunol. 65 (1986), 427-433.
18. Laufer, G., A. Laczkovics, G. Wollenek, P. Buxbaum, W. Graninger, C. Holzinger, E. Wolner: Infectious complications in heart transplant recipients with combined low dose cyclosporine, azathioprine and prednisolone immunosuppression. Transplant. Proc. 21 (1989), 2508-2511.
19. Lefebure, A. F., G. A. Verpooten, M. M. Couttenye, M. E. De Broe: Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine 11 (1993), 397-399.
20. Linnemann, C.J., M. R. First, G. Schiffmann: Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch. intern. Med. 146 (1986), 1554-1556.
21. Mond, J. J., Q. Vos, A. Lees, C. M. Snapper: T cell independent antigens. Curr. Opin. Immunol. 7 (1995), 349-354.
22. th ed. (1995), 1539-1572.
23. Musher, D. M., J. E. Groover, J. M. Rowland, D. A. Watson, J. B. Struewing, R. E. Baughn, M. A. Mufson: Antibodies to capsular polysaccharides of Streptococcus pneumoniae. Prevalence, persistence and response to revaccination. Clin. infect. Dis. 17 (1993), 66-73.
24. Obaro, S. K., D. C. Henderson, M. Monteil: Immunity to pneumococcal infections. Lancet 345 (1995), 70-71.
25. Petri, W. J.: Infections in heart transplant recipients. Clin. infect. Dis. 18 (1994), 141-146.
26. Reinert, R. R.: Antibiotic sensitivity of Streptococcus pneumoniae isolated from normally sterile body sites. J. infect. Dis. (1996), in press.
27. Reinert, R. R., A. Queck, A. Kaufhold, M. Kresken, R. Luetticken: Antibiotic sensitivity of Streptococcus pneumoniae isolated from normally sterile body sites. First results of a multicenter study in Germany. Infection 22 (1994), 113-114.
28. Rijkers, G. T., L. A. M. Sanders, B. J. M. Zegers: Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 5 (1993), 1-21.
29. Sanders, E. A., G. T. Rijkers, A. W. Griffioen, W. Kuis, B. J. Zegers: T cell function in patients with impaired antibody responses to polysaccharide antigens. Europ. J. Immunol. 21 (1991), 2293-2296.
30. Schaberg, T., H. Mauch, H. Lode: Klinische Bedeutung von penicillinresistenten Pneumokokken. Dtsch. med. Wschr. 118 (1993), 1491-1497.
31. Schiffmann, G.: Chemistry and immunochemistry of the pneumococcal polysaccharide vaccine with special reference to cross-reactions and immunologie factors. Rev. infect. Dis. 3 (1981), S18-S26.
32. Shapiro, E. D., A. T. Berg, R. Austrian, D. Schroeder, V. Parcells, A. Margolis, R. K. Adair, J. D. Clemens: The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. New Engl. J. Med. 325 (1991), 1453-1460.
33. Siber, G. R.: Pneumococcal disease. Prospects for a new generation of vaccines. Science 265 (1994), 1385-1389.
34. Simberkoff, M. S., A. P. Cross, I. M. Al, A. L. Baltch, P. J. Geiseler, J. Nadler, A. S. Richmond, R. P. Smith, G. Schiffmann, D. S. Shepard: Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administrations Cooperative study. New Engl. J. Med. 315 (1986), 1318-1327.
35. Wagner, D., I. Wagenbreth, R. Stachan-Kunstyr, J. Flik: Failure of vaccination against hepatitis B with Gen H-B-Vax in immunosuppressed heart transplant recipients. Clin. Invest. 70 (1992), 585-587.
36. Wagner, D., I. Wagenbreth, R. Stachan-Kunstyr, H. A. Thoma, H. E. Hemmerling, J. Flik: Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3. Clin. Invest. 72 (1994), 350-352.
37. Zielen, S., M. Broeker, N. Strnad, L. Schwenen, P. Bauscher, G. Gottwald, D. Hofmann: Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates. J. immunol. Methods (1995), in press.